Could a simple hormone help manage dangerous pregnancy condition?
NCT ID NCT02989025
First seen May 02, 2026 · Last updated Jun 23, 2026 · Updated 8 times
Summary
This study is testing whether giving progesterone (17 OHPC) to pregnant women with preeclampsia before 34 weeks can improve outcomes for them and their babies. The trial will enroll 60 women at the University of Mississippi Medical Center. Researchers will monitor blood pressure and other health measures to see if the hormone helps manage the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Winfred L. Wiser Hospital
RECRUITINGJackson, Mississippi, 39216, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
progesterone (17-hydroxyprogesterone caproate)
What this could lead to
If it works, this could point toward a way to manage preeclampsia in pregnancy, potentially improving health for both mother and baby.
What could go wrong
This is a small, early-phase pilot study with only 60 participants, so results may not apply widely. The drug may not improve outcomes or could have side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.